Age
Item
patients will be at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Peripheral neuropathic pain
Item
patients will be experiencing moderate to severe peripheral neuropathic pain
boolean
C0458960 (UMLS CUI [1])
Stable pain medication
Item
patients may be on chronic adjuvant pain medications such as antidepressants but must be on stable doses for at least one week prior to admission.
boolean
C0002771 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Opioid Use
Item
patients may be taking concurrent opioids but they must be willing to allow us to monitor their opioid use while on the trial.
boolean
C0240602 (UMLS CUI [1])
Peripheral neuropathic pain associated with chemotherapy
Item
patients must have chronic peripheral neuropathic pain will be defined as pain of 3 or more months duration which began in association with chemotherapy.
boolean
C0458960 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Peripheral pain symptoms involving the feet
Item
patient's will have bilateral peripheral neuropathic pain symptoms primarily involving the feet
boolean
C0458960 (UMLS CUI [1,1])
C0016504 (UMLS CUI [1,2])
Breast Cancer
Item
patients must have breast cancer (any stage)
boolean
C0678222 (UMLS CUI [1])
Language ability and informed consent
Item
patients must be able to read and speak english and provide informed consent.
boolean
C1145677 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Chemotherapy not causing peripheral neuropathy
Item
patients may be receiving chemotherapy as long as the agents are not known to cause a peripheral neuropathy.
boolean
C0392920 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,3])
C0031117 (UMLS CUI [1,4])
ECOG Performance Status
Item
patients must have an ecog performance status < 3 and be able to attend the physician study visits
boolean
C1520224 (UMLS CUI [1])
Gabapentin or pregabalin or anti-convulsant treatment
Item
patients must not concurrently use gabapentin or pregabalin or must be willing to wean off their anti-convulsant medications prior to starting the trial.
boolean
C0060926 (UMLS CUI [1])
C0657912 (UMLS CUI [2])
C0003299 (UMLS CUI [3])
Diabetes mellitus without neuropathy
Item
patients may have diabetes mellitus (type 1 or 2) as long as there is no preexisting neuropathy.
boolean
C0011849 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0011882 (UMLS CUI [1,3])
Secondary cause of neuropathic pain
Item
patients will not have secondary cause of neuropathic pain including: hiv/aids,traumatic injury, or a personal history of non chemotherapy-induced neuropathy.
boolean
C3714625 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
Major depression or severe anxiety
Item
patients will not have a history of major depression or severe anxiety.
boolean
C1269683 (UMLS CUI [1])
C0231403 (UMLS CUI [2])
Gynaecological Status
Item
women of childbearing age will agree to take measures to prevent pregnancy and will not breast-feed while on the study medication. women who are currently pregnant will not be invited to participate in this study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Seizures
Item
patients will not have a history of seizures.
boolean
C0036572 (UMLS CUI [1])
Antibiotic therapy for tuberculosis
Item
patients cannot be currently receiving antibiotic therapy for tuberculosis (e.g. isoniazid).
boolean
C0749724 (UMLS CUI [1])